Big Pharma Turns to Smaller Firms for Innovation

A wave of drugs coming off patents for large pharma firms has caused many to turn to smaller companies for inspiration. Companies use subsidiaries that scour the industry for drugs that are in development and then invest in bringing them through trials.
The Globe and Mail